Related Experiment Videos
[Metachromatic leukodystrophy (MLD) and Multiple sulphatase deficiency (MSD)]
1Department of Pediatrics, Tokyo Jikei University.
Abstract:
MLD is caused by a deficiency of arylsulfatase A and hence sulfolipids are accumulated in various patient's tissues. Various clinical phenotypes including activator deficiency, pseudodeficiency and MSD. Recently, molecular basis of these disorders have been identified. Clinical phenotype in MLD is well correlated with their genotype. Most common mutation in Caucasian MLD is caused by 609A mutation which produces late infantile MLD. In Japanese, most common mutation is 445A mutation. Essential treatment of MLD is recently carried out by bone marrow transplantation. On the hand, MSD is caused by multiple deficiencies of various sulfatases and hence accumulated various sulfated compounds such as sulfatide and acid mucopolysaccharides. The clinical features have combined characteristics of MLD and mucopolysaccharidosis. The cause of this disorder is recently identified as abnormal modification of various sulfatase.
Insights
Metachromatic leukodystrophy (MLD) results from arylsulfatase A deficiency, leading to sulfolipid accumulation. Understanding genotype-phenotype correlations and recent treatments like bone marrow transplantation is crucial for managing MLD and related disorders.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Context:
- Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder caused by arylsulfatase A deficiency.
- This deficiency leads to the accumulation of sulfolipids in various tissues, particularly the nervous system.
- MLD presents with diverse clinical phenotypes, including activator deficiency and pseudodeficiency, and is linked to specific genetic mutations.
Purpose:
- To elucidate the molecular basis and genotype-phenotype correlations in MLD.
- To differentiate MLD from other sulfatase-associated disorders like Multiple Sulfatase Deficiency (MSD).
- To highlight recent advancements in MLD treatment, such as bone marrow transplantation.
Summary:
- MLD arises from arylsulfatase A deficiency, causing sulfolipid buildup and varied clinical presentations.
- Genotype-phenotype correlations are established, with specific common mutations identified in Caucasian (609A) and Japanese (445A) populations.
- Multiple Sulfatase Deficiency (MSD) involves deficiencies in multiple sulfatases, leading to accumulation of sulfatides and mucopolysaccharides, presenting combined features of MLD and mucopolysaccharidosis.
Impact:
- Advances understanding of MLD's genetic underpinnings and ethnic variations in mutations.
- Provides insights into the pathophysiology of MSD, linking it to abnormal sulfatase modification.
- Identifies bone marrow transplantation as a key therapeutic strategy for MLD, offering hope for affected individuals.